SEC EDGAR / 2026-10-30

8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer)

Filed: 2026-10-30 AccNo: 0001628280-26-068627 Size: 140 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 8.01: Other Events

Read original source

Source page screenshot: 8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer) — Source page screenshot · www.sec.gov2026-11-06 UTC

Source record

Source: SEC EDGAR
Published: 2026-10-30 21:24:07 UTC
First discovered: 2026-10-31 09:00:18.261Z
Last collected: 2026-11-02 09:30:07.362Z
Author: Not provided
Topic: Other
Classification: Other stories
Evidence level: E1 · source record; conclusions unverified

Research analysis

Rule-based research guidance derived from the source record. Audience and commercial demand require validation.

Source record

Source account: Filed: 2026-10-30 AccNo: 0001628280-26-068627 Size: 140 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 8.01: Other Events

Available context

No comparable records or structured measurements are attached.

Research status

This record has not been assigned a sufficiently supported main content category. No commercial or performance conclusion is generated.

Missing evidence

The main event, affected audience and supporting primary source need review.

Next step

Read the original and identify the decision it supports before choosing an analysis framework.